Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
В. И. Евдокимов
Observed names:
V. Evdokimov,
V. I Evdokimov,
V. I. Evdokimov,
Vladimir Evdokimov,
Vladimir I. Evdokimov,
Владимир Игоревич Евдокимов
show all 6
Institution:
Moscow Multidisciplinary Clinical Center "Kommunarka"
Observed institutions:
Pirogov Russian National Research Medical University,
Ministry of Health of the Russian Federation,
Moscow Multidisciplinary Clinical Center "Kommunarka"
ORCID:
0000-0002-0591-7921
Observed ORCID:
0000-0002-0591-7921
OpenAlex ID:
A5103095638
Infectious Endocarditis Caused by a Rare Agent Burkholderia Cepacian
2018
·
N. S. Chipigina
, N. Yu. Karpova
, et al.
·
The Russian Archives of Internal Medicine
·
5
PDF
Biomarkers of resistance to anti-EGFR therapy in patients with left-sided colorectal cancer: a retrospective NGS analysis
2025
·
A. A. Lebedeva
, M. M. Byakhova
, et al.
·
Malignant tumours
·
1
PDF
327P TILVision: AI-based immune microenvironment prognostic model for stage I - III colorectal cancer
2026
·
O. Kuznetsova
, K. Murzakhanova
, et al.
·
Annals of Oncology
93eP Postoperative bacterial meningitis after neurosurgical tumour procedures: Comparing predictive approaches and identifying actionable risk factors
2026
·
N. Linde
, V. Evdokimov
, et al.
·
ESMO Real World Data and Digital Oncology
PDF
Comparative effectiveness of carboplatin- versus cisplatin-based first-line chemotherapy in cisplatin-eligible patients with metastatic urothelial carcinoma
2026
·
Avasherfe S. Ablyametova
, A. A. Rumyantsev
, et al.
·
Surgery and Oncology
Maintenance therapy with avelumab for metastatic urothelial cancer: data from real clinical practice
2026
·
A. S. Ablyametova
, A. A. Rumyantsev
, et al.
·
Malignant tumours
PDF
Гиперселекция пациентов при назначении анти-EGFR-антител. Первые результаты отечественного исследования
2025
·
Т. Г. Антонова
, М. М. Бяхова
, et al.
·
Malignant tumours
PDF
Предварительные результаты нерандомизированного многоцентрового исследования II фазы комбинации FOLFOX с панитумумабом/цетуксимабом и дабрафенибом в первой линии лечения метастатического колоректального рака с мутацией в гене BRAF и MSS фенотипом
2025
·
Е. С. Кузьмина
, М. Ю. Федянин
, et al.
·
Malignant tumours
PDF
Deriving Real-World Evidence from Non-English Electronic Medical Records in Hormone Receptor-Positive Breast Cancer Using Large Language Models
2025
·
Daur Meretukov
, Katerina Grechukhina
, et al.
·
Cancers
PDF
76P Text-to-treatment: Explainable ML predicts systemic therapy choice in cutaneous melanoma
2025
·
N. Linde
, V. Evdokimov
, et al.
·
ESMO Real World Data and Digital Oncology
Abemaciclib in real clinical practice of adjuvant therapy of HR+/HER2- high-risk breast cancer: experience of centers in Moscow
2025
·
Людмила Григорьевна Жукова
, Катерина Сергеевна Гречухина
, et al.
·
Voprosy Onkologii
Analysis of prognosis factors in patients with metastatic HER2‑positive gastric/cardioesophageal transition cancer treated in oncological clinics of Moscow
2025
·
R. Sh. Abdulaeva
, E. S. Obarevich
, et al.
·
Surgery and Oncology
PDF
Surgical treatment outcomes in patients with non-small cell lung cancer treated with neoadjuvant systemic therapy. A pilot single-center retrospective study
2025
·
A. V. Levitskiy
, V. Ju. Chemulova
, et al.
·
Siberian Journal of Oncology
PDF
Real-world experience with trastuzumab deruxtecan in patients with metastatic HER2-positive breast cancer and HER2-positive gastric cancer: A retrospective study
2023
·
Vladimir I. Evdokimov
, Anatoly A. Bloshchinenko
, et al.
·
Journal of Modern Oncology
PDF
Взаимозаменяемость анти-PD1 препаратов как инструмент реагирования на сложные условия финансирования
2023
·
М. Ю. Федянин
, Д. Г. Кравчук
, et al.
·
Malignant tumours
PDF
Show more works
View as search
Works count:
15
Citation count:
6
H-index:
1
I10-index:
Year
Topic
Type